57
Participants
Start Date
August 31, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
Single dose reduced
Treatment 1 (Part A)
Single dose standard
Treatment 2 (Part A)
Multiple Dose
Treatment 3 (Part A)
Multiple Dose
Part B
Research Site, London
Lead Sponsor
Collaborators (1)
Biogen
INDUSTRY
Knopp Biosciences
INDUSTRY